vs
CARLISLE COMPANIES INC(CSL)与Healthpeak Properties(DOC)财务数据对比。点击上方公司名可切换其他公司
CARLISLE COMPANIES INC的季度营收约是Healthpeak Properties的1.5倍($1.1B vs $719.4M),Healthpeak Properties净利率更高(73.2% vs 12.1%,领先61.0%),Healthpeak Properties同比增速更快(3.1% vs -4.0%),Healthpeak Properties自由现金流更多($357.0M vs $-73.0M),过去两年Healthpeak Properties的营收复合增速更高(8.9% vs -14.8%)
卡莱尔公司是专业建筑产品供应商,聚焦于提升建筑能效与稳固性,面向商业建筑领域生产销售单层屋面产品、质保系统及配套配件,旗下设有卡莱尔建筑材料、卡莱尔防水技术两大业务板块,产品涵盖防潮材料、屋面防护层等多个品类。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
CSL vs DOC — 直观对比
营收规模更大
CSL
是对方的1.5倍
$719.4M
营收增速更快
DOC
高出7.1%
-4.0%
净利率更高
DOC
高出61.0%
12.1%
自由现金流更多
DOC
多$430.0M
$-73.0M
两年增速更快
DOC
近两年复合增速
-14.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.1B | $719.4M |
| 净利润 | $127.7M | $114.0M |
| 毛利率 | 34.5% | — |
| 营业利润率 | 17.1% | 17.4% |
| 净利率 | 12.1% | 73.2% |
| 营收同比 | -4.0% | 3.1% |
| 净利润同比 | -10.9% | 2406.4% |
| 每股收益(稀释后) | $3.10 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CSL
DOC
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $719.4M | ||
| Q3 25 | $1.3B | $705.9M | ||
| Q2 25 | $1.4B | $694.3M | ||
| Q1 25 | $1.1B | $702.9M | ||
| Q4 24 | $1.1B | $698.0M | ||
| Q3 24 | $1.3B | $700.4M | ||
| Q2 24 | $1.5B | $695.5M |
净利润
CSL
DOC
| Q1 26 | $127.7M | — | ||
| Q4 25 | $127.4M | $114.0M | ||
| Q3 25 | $214.2M | $-117.1M | ||
| Q2 25 | $255.8M | $31.7M | ||
| Q1 25 | $143.3M | $42.8M | ||
| Q4 24 | $162.8M | $4.5M | ||
| Q3 24 | $244.3M | $85.9M | ||
| Q2 24 | $712.4M | $146.0M |
毛利率
CSL
DOC
| Q1 26 | 34.5% | — | ||
| Q4 25 | 33.8% | — | ||
| Q3 25 | 36.0% | 58.6% | ||
| Q2 25 | 37.3% | 60.2% | ||
| Q1 25 | 35.2% | 61.1% | ||
| Q4 24 | 36.1% | 60.3% | ||
| Q3 24 | 38.6% | 60.0% | ||
| Q2 24 | 39.2% | 60.6% |
营业利润率
CSL
DOC
| Q1 26 | 17.1% | — | ||
| Q4 25 | 16.8% | 17.4% | ||
| Q3 25 | 21.8% | 9.2% | ||
| Q2 25 | 23.1% | 5.7% | ||
| Q1 25 | 16.8% | 7.7% | ||
| Q4 24 | 19.9% | -2.2% | ||
| Q3 24 | 23.7% | 14.1% | ||
| Q2 24 | 26.0% | 22.3% |
净利率
CSL
DOC
| Q1 26 | 12.1% | — | ||
| Q4 25 | 11.3% | 73.2% | ||
| Q3 25 | 15.9% | -16.6% | ||
| Q2 25 | 17.6% | 4.6% | ||
| Q1 25 | 13.1% | 6.1% | ||
| Q4 24 | 14.5% | 0.7% | ||
| Q3 24 | 18.3% | 12.3% | ||
| Q2 24 | 49.1% | 21.0% |
每股收益(稀释后)
CSL
DOC
| Q1 26 | $3.10 | — | ||
| Q4 25 | $3.06 | $0.16 | ||
| Q3 25 | $4.98 | $-0.17 | ||
| Q2 25 | $5.88 | $0.05 | ||
| Q1 25 | $3.20 | $0.06 | ||
| Q4 24 | $3.76 | $0.02 | ||
| Q3 24 | $5.25 | $0.12 | ||
| Q2 24 | $14.84 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $771.3M | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $1.7B | $7.5B |
| 总资产 | — | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势,按日历期对齐
现金及短期投资
CSL
DOC
| Q1 26 | $771.3M | — | ||
| Q4 25 | $1.1B | $467.5M | ||
| Q3 25 | $1.1B | $91.0M | ||
| Q2 25 | $68.4M | $89.4M | ||
| Q1 25 | $220.2M | $70.6M | ||
| Q4 24 | $753.5M | $119.8M | ||
| Q3 24 | $1.5B | $180.4M | ||
| Q2 24 | $1.7B | $106.9M |
总债务
CSL
DOC
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $9.8B | ||
| Q3 25 | $2.9B | $9.1B | ||
| Q2 25 | $1.9B | $9.0B | ||
| Q1 25 | $1.9B | $8.9B | ||
| Q4 24 | $1.9B | $8.7B | ||
| Q3 24 | $2.3B | $8.6B | ||
| Q2 24 | $2.3B | $8.6B |
股东权益
CSL
DOC
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.8B | $7.5B | ||
| Q3 25 | $2.0B | $7.6B | ||
| Q2 25 | $2.1B | $7.9B | ||
| Q1 25 | $2.2B | $8.2B | ||
| Q4 24 | $2.5B | $8.4B | ||
| Q3 24 | $2.8B | $8.6B | ||
| Q2 24 | $3.0B | $8.8B |
总资产
CSL
DOC
| Q1 26 | — | — | ||
| Q4 25 | $6.3B | $20.3B | ||
| Q3 25 | $6.5B | $19.6B | ||
| Q2 25 | $5.5B | $19.8B | ||
| Q1 25 | $5.5B | $19.8B | ||
| Q4 24 | $5.8B | $19.9B | ||
| Q3 24 | $6.5B | $20.0B | ||
| Q2 24 | $6.7B | $20.2B |
负债/权益比
CSL
DOC
| Q1 26 | — | — | ||
| Q4 25 | 1.61× | 1.31× | ||
| Q3 25 | 1.45× | 1.20× | ||
| Q2 25 | 0.89× | 1.14× | ||
| Q1 25 | 0.87× | 1.08× | ||
| Q4 24 | 0.77× | 1.04× | ||
| Q3 24 | 0.83× | 1.00× | ||
| Q2 24 | 0.76× | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $-73.0M | $357.0M |
| 自由现金流率自由现金流/营收 | -6.9% | 49.6% |
| 资本支出强度资本支出/营收 | 2.7% | 124.4% |
| 现金转化率经营现金流/净利润 | — | 10.99× |
| 过去12个月自由现金流最近4个季度 | $924.8M | — |
8季度趋势,按日历期对齐
经营现金流
CSL
DOC
| Q1 26 | — | — | ||
| Q4 25 | $386.0M | $1.3B | ||
| Q3 25 | $426.9M | $315.0M | ||
| Q2 25 | $287.1M | $363.5M | ||
| Q1 25 | $1.8M | $279.4M | ||
| Q4 24 | $370.6M | $1.1B | ||
| Q3 24 | $312.8M | $318.2M | ||
| Q2 24 | $183.4M | $316.2M |
自由现金流
CSL
DOC
| Q1 26 | $-73.0M | — | ||
| Q4 25 | $346.1M | $357.0M | ||
| Q3 25 | $393.4M | — | ||
| Q2 25 | $258.3M | — | ||
| Q1 25 | $-27.2M | — | ||
| Q4 24 | $334.0M | $333.7M | ||
| Q3 24 | $293.5M | — | ||
| Q2 24 | $158.5M | — |
自由现金流率
CSL
DOC
| Q1 26 | -6.9% | — | ||
| Q4 25 | 30.7% | 49.6% | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | 29.7% | 47.8% | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 10.9% | — |
资本支出强度
CSL
DOC
| Q1 26 | 2.7% | — | ||
| Q4 25 | 3.5% | 124.4% | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 3.3% | 105.6% | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 1.7% | — |
现金转化率
CSL
DOC
| Q1 26 | — | — | ||
| Q4 25 | 3.03× | 10.99× | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 1.12× | 11.48× | ||
| Q1 25 | 0.01× | 6.52× | ||
| Q4 24 | 2.28× | 235.43× | ||
| Q3 24 | 1.28× | 3.71× | ||
| Q2 24 | 0.26× | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSL
| CCM | $758.0M | 72% |
| CWT | $294.0M | 28% |
DOC
暂无分部数据